Kimberly Stegmaier has been named as Pediatric Oncology Chair at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn:
“Kimberly Stegmaier, MD, has been named as Pediatric Oncology Chair. She will also serve as Associate Chief of Division of Hematology/Oncology at Boston Children’s Hospital. Please join us in congratulating her on this achievement.
Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared this post, adding:
“Congratulations to Kimberly Stegmaier, MD, on being named the next Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital.
I am proud to know and to have worked alongside Kim for many years. She is deeply devoted to our young patients and their families and to the quest for new therapies. I am excited for her to lead our Department of Pediatric Oncology and to build on its strong foundation for years to come.”
More posts featuring Dana-Farber Cancer Institute and Benjamin Ebert.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023